Hye-Young Min Selected Research

Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

7/2020

The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hye-Young Min Research Topics

Disease

56	Neoplasms (Cancer) 09/2023 - 06/2003
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2011
17	Lung Neoplasms (Lung Cancer) 08/2023 - 10/2004
16	Carcinogenesis 09/2023 - 01/2002
7	Inflammation (Inflammations) 01/2024 - 01/2002
7	Colonic Neoplasms (Colon Cancer) 01/2023 - 04/2003
7	Neoplasm Metastasis (Metastasis) 03/2021 - 12/2005
5	Body Weight (Weight, Body) 09/2023 - 08/2012
5	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2009
5	Fibrosarcoma 08/2012 - 11/2005
4	Squamous Cell Carcinoma of Head and Neck 03/2021 - 12/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 05/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2012
2	Pulmonary Emphysema 05/2020 - 05/2020
2	Emphysema 05/2020 - 05/2020
2	Hematologic Neoplasms (Hematological Malignancy) 03/2017 - 06/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2008
6	CarcinogensIBA 09/2023 - 01/2011
6	Insulin-Like PeptidesIBA 03/2021 - 05/2013
4	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 12/2005
4	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2021 - 06/2015
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2012 - 12/2005
4	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 12/2005
3	EnzymesIBA 01/2024 - 10/2007
3	ResveratrolIBA 01/2024 - 04/2003
3	falcarinolIBA 08/2023 - 01/2018
3	evodiamineIBA 01/2023 - 03/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 03/2012
3	deguelinIBA 01/2022 - 05/2013
3	StilbenesIBA 08/2012 - 10/2004
3	AlkaloidsIBA 03/2012 - 11/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2011 - 01/2002
3	ZincIBA 05/2006 - 12/2005
3	Peptide Hydrolases (Proteases)FDA Link 05/2006 - 12/2005
3	Messenger RNA (mRNA)IBA 05/2006 - 12/2005
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2023 - 01/2021
2	CateninsIBA 04/2022 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2020
2	Insulin-Like Growth Factor Binding Protein 3IBA 03/2021 - 11/2012
2	Coloring Agents (Dyes)IBA 01/2021 - 07/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 10/2016
2	Activating Transcription Factor 6IBA 07/2020 - 01/2020
2	CytokinesIBA 05/2020 - 01/2020
2	Adenosine A3 ReceptorIBA 05/2020 - 05/2020
2	Pancreatic Elastase (Elastase)IBA 05/2020 - 05/2020
2	gracillinIBA 04/2020 - 10/2019
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2015
2	IntegrinsIBA 01/2020 - 10/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2017 - 06/2015
2	Vorinostat FDA Link 03/2017 - 06/2015
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 11/2016 - 09/2016
2	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 10/2016 - 09/2016
2	Histone Deacetylase InhibitorsIBA 06/2015 - 11/2012
2	cixutumumabIBA 10/2013 - 12/2011
2	pinosylvinIBA 08/2012 - 12/2004
2	phenanthroindolizidineIBA 03/2012 - 11/2010
2	antofineIBA 03/2012 - 11/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011 - 10/2004
2	Estrogen ReceptorsIBA 02/2010 - 05/2009
2	LignansIBA 05/2009 - 01/2008
2	Ether (Diethyl Ether)IBA 09/2008 - 03/2005
2	Adenosine (Adenocard)FDA LinkGeneric 06/2008 - 09/2005
2	thio-Cl-IB-MECAIBA 06/2008 - 09/2005
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2008 - 09/2005
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2007 - 06/2003
2	ProstaglandinsIBA 10/2007 - 01/2002
2	Tissue Inhibitor of Metalloproteinase-2IBA 05/2006 - 12/2005
2	indoleIBA 12/2005 - 10/2004
2	Tissue Inhibitor of MetalloproteinasesIBA 12/2005 - 12/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2005 - 01/2002
1	Sirtuin 1IBA 01/2024
1	Particulate MatterIBA 01/2024
1	Histones (Histone)IBA 01/2024
1	CholesterolIBA 09/2023
1	Triglycerides (Triacylglycerol)IBA 09/2023
1	HDL LipoproteinsIBA 09/2023
1	Benzo(a)pyreneIBA 09/2023
1	Blood Glucose (Blood Sugar)IBA 09/2023
1	trans-sodium crocetinate (crocetin)IBA 09/2023
1	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 09/2023
1	Glucose (Dextrose)FDA LinkGeneric 09/2023
1	EstersIBA 03/2023
1	6-carboxyfluorescein (carboxyfluorescein)IBA 03/2023
1	ReninIBA 01/2023
1	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 01/2023
1	neorautenolIBA 01/2023
1	AngiotensinsIBA 01/2023
1	Monoclonal AntibodiesIBA 10/2022
1	LigandsIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 03/2021

Therapy/Procedure

11	Therapeutics 10/2022 - 05/2013
8	Drug Therapy (Chemotherapy) 01/2022 - 03/2012
2	Molecular Targeted Therapy 10/2022 - 01/2018
1	Precision Medicine 10/2022